153 related articles for article (PubMed ID: 18691854)
1. Epoetin delta: efficacy in the treatment of anaemia in cancer patients receiving chemotherapy.
Krzakowski M;
Clin Oncol (R Coll Radiol); 2008 Nov; 20(9):705-13. PubMed ID: 18691854
[TBL] [Abstract][Full Text] [Related]
2. Epoetin delta is effective for the management of anaemia associated with chronic kidney disease.
Spinowitz BS; Pratt RD;
Curr Med Res Opin; 2006 Dec; 22(12):2507-13. PubMed ID: 17166333
[TBL] [Abstract][Full Text] [Related]
3. Once-weekly epoetin beta therapy in patients with solid tumours and chemotherapy-induced anaemia: a randomized, double-blind, dose-finding study.
Heras P; Kritikos K; Hatzopoulos A; Mitsibounas D
Eur J Cancer Care (Engl); 2008 Nov; 17(6):619-23. PubMed ID: 18707619
[TBL] [Abstract][Full Text] [Related]
4. Epoetin delta, erythropoietin produced in a human cell line, in the management of anaemia in predialysis chronic kidney disease patients.
Kwan JT; Pratt RD;
Curr Med Res Opin; 2007 Feb; 23(2):307-11. PubMed ID: 17288685
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.
Silver M; Corwin MJ; Bazan A; Gettinger A; Enny C; Corwin HL
Crit Care Med; 2006 Sep; 34(9):2310-6. PubMed ID: 16878035
[TBL] [Abstract][Full Text] [Related]
6. Epoetin delta in the management of renal anaemia: results of a 6-month study.
Martin KJ;
Nephrol Dial Transplant; 2007 Oct; 22(10):3052-4. PubMed ID: 17660186
[TBL] [Abstract][Full Text] [Related]
7. Phase III, randomized, double-blind study of epoetin alfa compared with placebo in anemic patients receiving chemotherapy.
Witzig TE; Silberstein PT; Loprinzi CL; Sloan JA; Novotny PJ; Mailliard JA; Rowland KM; Alberts SR; Krook JE; Levitt R; Morton RF
J Clin Oncol; 2005 Apr; 23(12):2606-17. PubMed ID: 15452187
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy of weekly epoetin Beta in the treatment of chemotherapy-induced anemia in solid tumors].
Oudard S; Quoix E; Jenabian A; Bergougnoux L; Chouahnia K; Ferrero JM; Misset JL; Spaëth D
Therapie; 2009; 64(1):17-25. PubMed ID: 19463249
[TBL] [Abstract][Full Text] [Related]
9. Weekly administration of epoetin beta for chemotherapy-induced anemia in cancer patients: results of a multicenter, Phase III, randomized, double-blind, placebo-controlled study.
Tsuboi M; Ezaki K; Tobinai K; Ohashi Y; Saijo N
Jpn J Clin Oncol; 2009 Mar; 39(3):163-8. PubMed ID: 19164318
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the therapeutic effects of epoetin zeta to epoetin alfa in the maintenance phase of renal anaemia treatment.
Wizemann V; Rutkowski B; Baldamus C; Scigalla P; Koytchev R;
Curr Med Res Opin; 2008 Mar; 24(3):625-37. PubMed ID: 18208642
[TBL] [Abstract][Full Text] [Related]
11. Weekly epoetin beta maintains haemoglobin levels and improves quality of life in patients with non-myeloid malignancies receiving chemotherapy.
Suzuki Y; Tokuda Y; Fujiwara Y; Minami H; Ohashi Y; Saijo N
Jpn J Clin Oncol; 2008 Mar; 38(3):214-21. PubMed ID: 18296425
[TBL] [Abstract][Full Text] [Related]
12. Early intervention with epoetin beta prevents severe anaemia in patients with solid tumours receiving platinum-based chemotherapy: results of the NeoPrevent study.
de Castro J; Ordóñez A; Isla D; Sánchez A; Arrivi A; Manzano JL; Barón MG
Cancer Chemother Pharmacol; 2007 Jan; 59(1):35-42. PubMed ID: 16874498
[TBL] [Abstract][Full Text] [Related]
13. Outcomes and predicting response in anaemic chemotherapy patients treated with epoetin alfa. A multicentre, 4-month, open-label study in Australia and New Zealand.
Bell D; Grimes D; Gurney H; Dalley D; Blackwell T; Fox R; Jeffery M
Intern Med J; 2008 Oct; 38(10):751-7. PubMed ID: 19143877
[TBL] [Abstract][Full Text] [Related]
14. Anaemia management with epoetin alfa in lung cancer patients in The Netherlands.
Biesma B; van de Werf PR; Melissant CF; Brok RG
Lung Cancer; 2007 Oct; 58(1):104-11. PubMed ID: 17601632
[TBL] [Abstract][Full Text] [Related]
15. Recombinant human erythropoietin in the treatment of cancer and chemotherapy-induced anemia: results of double-blind and open-label follow-up studies.
Henry DH; Abels RI
Semin Oncol; 1994 Apr; 21(2 Suppl 3):21-8. PubMed ID: 8202722
[TBL] [Abstract][Full Text] [Related]
16. Early intervention with epoetin beta prevents severe anaemia in lung cancer patients receiving platinum-based chemotherapy: a subgroup analysis of the NeoPrevent study.
de Castro J; Belda-Iniesta C; Isla D; Dómine M; Sánchez A; Batiste E; Barón MG
Lung Cancer; 2008 Feb; 59(2):211-8. PubMed ID: 17875340
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic effects of epoetin zeta in the treatment of chemotherapy-induced anaemia.
Tzekova V; Mihaylov G; Elezovic I; Koytchev R;
Curr Med Res Opin; 2009 Jul; 25(7):1689-97. PubMed ID: 19505200
[TBL] [Abstract][Full Text] [Related]
18. Epoetin beta (NeoRecormon) therapy in patients with solid tumours receiving platinum and non-platinum chemotherapy: a meta-analysis.
Boogaerts M; Oberhoff C; Ten Bokkel Huinink W; Nowrousian MR; Hayward CR; Burger HU
Anticancer Res; 2006; 26(1B):479-84. PubMed ID: 16739308
[TBL] [Abstract][Full Text] [Related]
19. Prior red blood cell transfusions in cancer patients increase the risk of subsequent transfusions with or without recombinant human erythropoietin management.
Couture F; Turner AR; Melosky B; Xiu L; Plante RK; Lau CY; Quirt I
Oncologist; 2005 Jan; 10(1):63-71. PubMed ID: 15632253
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety analysis of epoetin alfa in patients with small-cell lung cancer: a randomized, double-blind, placebo-controlled trial.
Grote T; Yeilding AL; Castillo R; Butler D; Fishkin E; Henry DH; DeLeo M; Fink K; Sullivan DJ
J Clin Oncol; 2005 Dec; 23(36):9377-86. PubMed ID: 16361638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
